The bill introduces amendments to existing statutes, particularly regarding the definitions related to employment and participation in clinical trials. By defining participants in these trials as independent from standard employee classifications, AB398 aims to alleviate potential liabilities for employers involved in clinical research. This is viewed as a significant step in encouraging clinical trials by reducing regulatory burdens associated with employment laws that may otherwise apply to those participants.
Summary
Assembly Bill 398 aims to clarify the legal status of participants in clinical research trials in the context of employment law in Wisconsin. It specifies that individuals participating in these trials and receiving payments, stipends, or compensation will not be classified as employees of the trial's conducting entity. This change is intended to provide a clear distinction for labor laws, ensuring that such participation does not constitute traditional employment under worker's compensation or minimum wage statutes.
Contention
While proponents argue that this bill will foster more participation in clinical trials, critics raise concerns regarding the implications for workers' rights. By delineating that compensation for trial participation is excluded from employee wages and benefits, some fear it may undermine necessary protections that should be afforded to all individuals receiving remuneration. This contention highlights the broader discussion on balancing the need for innovation in medical research with the rights and protections of individuals involved.
Delivery network couriers and transportation network drivers, Department of Financial Institutions’ approval to offer portable benefit accounts, providing for insurance coverage, modifying administrative rules related to accident and sickness insurance, and granting rule-making authority. (FE)